We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
+16.12%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$17.3B
AUM Growth
+$6.88B
(+66%)
Cap. Flow
+$6.5B
Cap. Flow
% of AUM
37.62%
Top 10 Holdings %
Top 10 Hldgs %
46.83%
Holding
2,057
New
934
Increased
622
Reduced
249
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Large Cap Deep Quarterly Laddered ETF
IVVB
|
+$1.81B |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$893M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$111M |
| 5 |
Amazon
AMZN
|
+$89.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$189M |
| 2 |
NVIDIA
NVDA
|
+$73.1M |
| 3 |
Pfizer
PFE
|
+$48.6M |
| 4 |
Blackrock
BLK
|
+$41.2M |
| 5 |
Apple
AAPL
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.5% |
| 2 | Financials | 6.1% |
| 3 | Industrials | 4.6% |
| 4 | Consumer Discretionary | 3.96% |
| 5 | Communication Services | 3.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Codexis
CDXS
$158M
| $103K | ﹤0.01% |
42,029
-8,808
| -17% | -$20.7K |
|
|
ZIMV
1777
DELISTED
ZimVie
ZIMV
| $102K | ﹤0.01% |
+10,937
| New | +$99.9K |
|
1778
Arcus Biosciences
RCUS
$3.64B
| $97.5K | ﹤0.01% |
+11,972
| New | +$102K |
|
1779
Quanterix
QTRX
$190M
| $96.5K | ﹤0.01% |
+14,505
| New | +$80.8K |
|
1780
Shoals Technologies Group
SHLS
$1.5B
| $96.4K | ﹤0.01% |
22,689
-224,405
| -91% | -$975K |
|
1781
OmniAb
OABI
$447M
| $93.6K | ﹤0.01% |
+53,779
| New | +$90K |
|
1782
Allogene Therapeutics
ALLO
$694M
| $92.5K | ﹤0.01% |
81,843
-163,774
| -67% | -$218K |
|
|
TEAD
1783
Teads Holding Co
TEAD
$67.7M
| $90.7K | ﹤0.01% |
+36,562
| New | +$111K |
|
1784
N-able
NABL
$940M
| $90.3K | ﹤0.01% |
+11,152
| New | +$83.3K |
|
|
UDMY
1785
DELISTED
Udemy
UDMY
| $90K | ﹤0.01% |
12,797
-13,763
| -52% | -$94.9K |
|
1786
Lucid Motors
LCID
$2.77B
| $87.8K | ﹤0.01% |
+4,163
| New | +$99.7K |
|
|
HPP
1787
Hudson Pacific Properties
HPP
$779M
| $80.7K | ﹤0.01% |
+4,208
| New | +$68.3K |
|
1788
Kura Oncology
KURA
$850M
| $80.4K | ﹤0.01% |
+13,929
| New | +$85.3K |
|
|
ONTF
1789
DELISTED
ON24
ONTF
| $78.3K | ﹤0.01% |
+14,416
| New | +$73.9K |
|
1790
New Fortress Energy
NFE
$101M
| $77.2K | ﹤0.01% |
+23,250
| New | +$101K |
|
|
ESPR
1791
DELISTED
Esperion Therapeutics
ESPR
| $77.1K | ﹤0.01% |
78,715
+45,782
| +139% | +$45.8K |
|
1792
Rayonier Advanced Materials
RYAM
$610M
| $74.8K | ﹤0.01% |
19,417
-22,850
| -54% | -$96K |
|
1793
RLJ Lodging Trust
RLJ
$1.69B
| $73.5K | ﹤0.01% |
10,100
-133,608
| -93% | -$963K |
|
1794
Cerus
CERS
$474M
| $67.4K | ﹤0.01% |
47,823
+33,249
| +228% | +$44.3K |
|
|
SRG
1795
Seritage Growth Properties
SRG
$136M
| $64.3K | ﹤0.01% |
20,867
+9,839
| +89% | +$28.3K |
|
1796
Kaltura
KLTR
$267M
| $63.8K | ﹤0.01% |
31,760
+15,614
| +97% | +$32.3K |
|
1797
Akebia Therapeutics
AKBA
$252M
| $62.4K | ﹤0.01% |
+17,148
| New | +$47.1K |
|
1798
Montauk Renewables
MNTK
$255M
| $59.4K | ﹤0.01% |
26,774
+10,911
| +69% | +$23.1K |
|
1799
Oxford Square Capital
OXSQ
$157M
| $58.6K | ﹤0.01% |
26,282
-2,770
| -10% | -$6.64K |
|
1800
3D Systems Corp
DDD
$613M
| $57.6K | ﹤0.01% |
+37,401
| New | +$67.7K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
GIM
DWM
MIFH
Brevan Howard Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Brevan Howard Capital Management held 2,057 positions worth $17.3B, up 66% from $10.4B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Brevan Howard Capital Management deployed $6.5B of net new capital in Q2 2025, opening 934 new positions and adding to 622 existing holdings. Its largest new stake was iShares Large Cap Deep Quarterly Laddered ETF: 60,706,457 shares worth $461M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 4.6% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was NVIDIA, an estimated $73.1M trimmed.
- Brevan Howard Capital Management's largest Q2 2025 buy was iShares Large Cap Deep Quarterly Laddered ETF: 60,706,457 shares worth $461M.
- Brevan Howard Capital Management added most to iShares Bitcoin Trust in Q2 2025, an estimated $893M increase.
- Brevan Howard Capital Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $73.1M.
- Brevan Howard Capital Management fully exited iShares MSCI Emerging Markets ETF in Q2 2025, selling an estimated $189M.
- Brevan Howard Capital Management's ten largest holdings make up 47% of its $17.3B portfolio in Q2 2025.
- Brevan Howard Capital Management opened 934 new positions and closed 240 in Q2 2025.
- Brevan Howard Capital Management's portfolio value rose 66% quarter-over-quarter to $17.3B.
Based on Brevan Howard Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.